Paul J. Clancy, Executive VP and CFO at BIOGEN IDEC INC. (BIIB), sold 19,716 shares at $99.27 ($2.0M) on 2011-04-28, disclosed to the SEC on 2011-04-29.
Scheduled sale ($2.0M) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.75 | 874 | $86K | 4.4% |
| 2 | $98.83 | 4,061 | $401K | 20.6% |
| 3 | $98.83 | 1,263 | $125K | 6.4% |
| 4 | $98.85 | 8,705 | $860K | 44.1% |
| 5 | $98.86 | 1,657 | $164K | 8.4% |
| 6 | $99.12 | 485 |
| $48K |
| 2.5% |
| 7 | $99.27 | 700 | $69K | 3.6% |
| 8 | $99.28 | 1,300 | $129K | 6.6% |
| 9 | $99.36 | 291 | $29K | 1.5% |
| 10 | $99.36 | 290 | $29K | 1.5% |
| 11 | $99.69 | 90 | $9K | 0.5% |
| Total | $98.91 avg | 19,716 | $2.0M | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |